Takeda Pharmaceutical has stepped up with a $25 million investment in Cleveland’s BioMotiv, buying into the accelerator’s promise to transform academic discoveries into market-bound therapeutics.
Researchers have found a way to take a pediatric patient’s skin cells, reprogram the skin cells to function as heart valvular cells, and then use the cells as part of a tissue-engineered pulmonary valve. A proof of concept study published in the September 2014 issue of The Annals of Thoracic Surgery provides more detail on this scientific development.
Originally posted by MobiHealthNews, who has been tracking FDA clearances for smartphone-connected medical devices and standalone apps for many years. So far 2014 has had its fair share — about two dozen digital health-related FDA clearances have been secured this year. Here’s a roundup:
A new wearable medical device can quickly alert a person if they are having cardiovascular trouble or if it’s simply time to put on some skin moisturizer, reports a Northwestern University and University of Illinois at Urbana-Champaign study.
Amid growing concern over the cybersecurity of medical devices, the FDA is weighing in on the issue and addressing product safety at an upcoming conference.
With just a week to go before the expected release of pharma and med tech companies’ payments to physicians under the Sunshine Act, stakeholders are still in the dark about what the website will look like. The medical device industry association has long been lobbying the federal Center for Medicare & Medicaid Services to provide…